Related Experiment Video
Updated: May 6, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
Published on: October 12, 2014
[SARS-CoV-2 Infection in Heart Transplant Recipients]
Jhoel Yarahuaman-Mora1, Juan Muñoz-Moreno1, Walter Alarco-León2
1Médico residente de Cardiología. Instituto Nacional Cardiovascular - INCOR EsSalud. Lima, Perú. Médico residente de Cardiología Instituto Nacional Cardiovascular - INCOR EsSalud Lima Perú.
Insights
This study details two heart transplant recipients diagnosed with severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2). It highlights the limited information on COVID-19 outcomes in immunocompromised transplant patients.
Area of Science:
- Medicine
- Virology
- Immunology
Background:
- The global spread of SARS-CoV-2 has led to significant morbidity and mortality.
- Solid organ transplant recipients are a vulnerable population due to long-term immunosuppression.
- Limited data exists on the clinical presentation, course, and management of COVID-19 in transplant patients.
Abstract:
Since the first reports of SARS-CoV-2 infection in December 2019 in Wuhan, China, we have witnessed its worldwide spread, and the serious complications it caused in thousands of patients. Recipients of solid organ transplants are among the risk population due to immunosuppression.There is lack of information about the presentation, clinical course, management, and prognosis of coronavirus disease (COVID-19) in these patients.We present 2 cases of heart transplant recipients who contracted SARS-CoV-2 infection and received treatment in a Cardiology Institute in Lima, Peru.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy

